These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 17125213)

  • 1. 3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors.
    Weber A; Böhm M; Supuran CT; Scozzafava A; Sotriffer CA; Klebe G
    J Chem Inf Model; 2006; 46(6):2737-60. PubMed ID: 17125213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated approach using protein and ligand information to analyze selectivity- and affinity-determining features of carbonic anhydrase isozymes.
    Hillebrecht A; Supuran CT; Klebe G
    ChemMedChem; 2006 Aug; 1(8):839-53. PubMed ID: 16902938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of human carbonic anhydrase II: docking reliability and receptor-based 3D-QSAR study.
    Tuccinardi T; Nuti E; Ortore G; Supuran CT; Rossello A; Martinelli A
    J Chem Inf Model; 2007; 47(2):515-25. PubMed ID: 17295464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
    Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A
    J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 3D QSAR models for database screening: a feasibility study.
    Hillebrecht A; Klebe G
    J Chem Inf Model; 2008 Feb; 48(2):384-96. PubMed ID: 18211050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
    Innocenti A; Maresca A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3938-41. PubMed ID: 18572406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-QSAR study of sulfonamide inhibitors of human carbonic anhydrase II.
    Huang H; Pan X; Tan N; Zeng G; Ji C
    Eur J Med Chem; 2007 Mar; 42(3):365-72. PubMed ID: 17118494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
    Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
    J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II.
    Eroglu E; Türkmen H
    J Mol Graph Model; 2007 Nov; 26(4):701-8. PubMed ID: 17493855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
    Tarko L; Supuran CT
    Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
    Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
    Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
    Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
    Kamath S; Buolamwini JK
    J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.